Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period

Accident Analysis and Prevention

Volumn 62, Issue , 2014, Pages 26-31

  Tuv, Silja Skogstad ^a   Krabseth, Hege ^a   Karinen, Ritva ^a   Olsen, Kirsten M ^a   Iestad, Elisabeth L ^a   Vindenes, Vigdis ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

AM 2201; DUID; JWH 018; Prevalence; Synthetic cannabinoids; UPLC MS MS

Indexed keywords

AM-2201; DUID; JWH-018; PREVALENCE; SYNTHETIC CANNABINOIDS; UPLC-MS/MS;

AUTOMOBILE DRIVERS; BLOOD; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

SCREENING;

(4-METHYL-1-NAPHTHYL)-(1-PENTYLINDOL-3-YL)METHANONE; 1-(1- PENTYL-1H-INDOL-3-YL)-2-(2-METHOXYPHENYL)ETHANONE; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; ANISOLE DERIVATIVE; CANNABINOID; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE; STREET DRUG;

ADOLESCENT; ADULT; BLOOD; CAR DRIVING; COHORT ANALYSIS; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; NORWAY; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

AM-2201; DUID; JWH-018; PREVALENCE; SYNTHETIC CANNABINOIDS; UPLC-MS/MS;

ADOLESCENT; ADULT; ANISOLES; AUTOMOBILE DRIVING; CANNABINOIDS; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; NAPHTHALENES; NORWAY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84886390109     PISSN: 00014575     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aap.2013.09.009     Document Type: Article

References (43)

1. S. Banerji, Cm Deutsch, and B. Ac Spice ain't so nice Clin. Toxicol. 48 2010 632
2. V.S. Bebarta, S. Ramirez, and S.M. Varney Complication of spice use in a deployed combat setting-seizure while on duty Am. J. Addict. 21 5 2012 496 497
3. J.G. Bramness, S. Skurtveit, and J. Morland Testing for benzodiazepine inebriation-relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers Eur. J. Clin. Pharmacol. 59 8-9 2003 593 601 (Pubitemid 37494526)
4. H. Choi, S. Heo, S. Choe, W. Yang, Y. Park, E. Kim, H. Chung, and J. Lee Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS Anal. Bioanal. Chem. 2012
5. A.S. Christophersen, H. Gjerde, A. Bjorneboe, J. Sakshaug, and J. Morland Screening for drug use among Norwegian drivers suspected of driving under influence of alcohol or drugs Forensic Sci. Int. 45 1-2 1990 5 14 (Pubitemid 20104345)
6. S.R. Dahl, K.M. Olsen, and D.H. Strand Determination of gamma-hydroxybutyrate (GHB), beta-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and gamma-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 885-886 2012 37 42
7. O.H. Drummer, J. Gerostamoulos, H. Batziris, M. Chu, J.R. Caplehorn, M.D. Robertson, and P. Swann The incidence of drugs in drivers killed in australian road traffic crashes Forensic Sci. Int. 134 2-3 2003 154 162 (Pubitemid 36808942)
8. Emcdda Tecnical Report MDPV. The Psychonaut Project 2010
9. L. Fattore, and W. Fratta Beyond THC: the new generation of cannabinoid designer drugs Frontiers Behav. Neurosci. 5 2011
10. Fhi Rusmiddelstatistikk funn i blodprøver hos bilførerere mistenkt for påvirket kjøring 2010 2010 National Institute of Public Health
11. P. Griffifths, R. Sedefov, A. Gallegos, and D. Lopez How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study Addiction 105 6 2010 951 953
12. F. Grotenhermen Pharmacokinetics and pharmacodynamics of cannabinoids Clin. Pharmacokinet. 42 4 2003 327 360 (Pubitemid 36433875)
13. I. Gustavsen, M. Al-Sammurraie, J. Morland, and J.G. Bramness Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers Accid. Anal. Prev. 41 3 2009 462 466
14. I. Gustavsen, J. Morland, and J.G. Bramness Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers Accid. Anal. Prev. 38 3 2006 490 495
15. R. Heltsley, M.K. Shelby, D.J. Crouch, D.L. Black, T.A. Robert, L. Marshall, C.L. Bender, A.Z. Depriest, and M.A. Colello Prevalence of synthetic cannabinoids in U.S. athletes: initial findings J. Anal. Toxicol. 36 8 2012 588 593
16. X. Hu, B.A. Primack, T. Barnett, and R.L. Cook Prevalence of K2 use among college students Am. J. Epidemiol. 173 2011 S64
17. X. Hu, B.A. Primack, T.E. Barnett, and R.L. Cook College students and use of K2: an emerging drug of abuse in young persons Subst. Abuse Treat. Prev. Policy 6 2011 16 16
18. A.W. Jones Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment Addiction 102 7 2007 1085 1091 (Pubitemid 46918660)
19. H.Z. Khiabani, J.G. Bramness, A. Bjorneboe, and J. Morland Relationship between thc concentration in blood and impairment in apprehended drivers Traffic Inj. Prev. 7 2 2006 111 116
20. L. Kristoffersen, L.E. Stormyhr, and A. Smith-Kielland Headspace gas chromatographic determination of ethanol: the use of factorial design to study effects of blood storage and headspace conditions on ethanol stability and acetaldehyde formation in whole blood and plasma Forensic Sci. Int. 161 2-3 2006 151 157 (Pubitemid 44142905)
21. M.C. Longo, C.E. Hunter, R.J. Lokan, J.M. White, and M.A. White The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: Part i: the prevalence of drug use in drive the drug-positive group Accid. Anal. Prev. 32 5 2000 613 622
22. I. Moller, A. Wintermeyer, K. Bender, M. Jubner, A. Thomas, O. Krug, W. Schanzer, and M. Thevis Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls Drug Test. Anal. 3 9 2011 609 620
23. F. Musshoff, B. Madea, G. Kernbach-Wighton, W. Bicker, S. Kneisel, M. Hutter, and V. Auwarter Driving under the influence of synthetic cannabinoids ("spice"): a case series Int. J. Legal Med. 2013
24. E.L. Oiestad, U. Johansen, A.M. Oiestad, and A.S. Christophersen Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry J. Anal. Toxicol. 35 5 2011 280 293
25. T. Passie, J.H. Halpern, D.O. Stichtenoth, H.M. Emrich, and A. Hintzen The pharmacology of lysergic acid diethylamide: a review CNS Neurosci. Ther. 14 4 2008 295 314
26. C. Piggee Investigating a not-so-natural high Anal. Chem. 81 9 2009 3205 3207
27. B. Presley, S. Jansen-Varnum, and B. Logan Analysis of synthetic cannabinoids in botanical material: a review of analytical methods and findings Forensic Sci. Rev. 25 2013
28. J.G. Ramaekers, H.W. Robbe, and J.F. O'hanlon Marijuana, alcohol and actual driving performance Hum. Psychopharmacol. 15 7 2000 551 558
29. V.M. Showalter, D.R. Compton, B.R. Martin, and M.E. Abood Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands J. Pharmacol. Exp. Ther. 278 3 1996 989 999 (Pubitemid 27166944)
30. Slv Statens legemiddelverk narkotikaforskrift 2013
31. K. Smith, and J. Flatley Drug Misuse Declared: Findings from the 2010/11 British Crime Survey 2011 Home Office Statistical Bulletin Home Office
32. G.A. Thakur, S.P. Nikas, and A. Makriyannis CB1 cannabinoid receptor ligands Mini-Rev. Med. Chem. 5 7 2005 631 640 (Pubitemid 40933034)
33. S.S. Tuv, M.C. Strand, R. Karinen, E.L. ∅iestad, A.S. Christophersen, and V. Vindenes Effect and occurrence of synthetic cannabinoids Tidsskr. Nor. Laegeforen. 132 2012 2285 2288
34. I. Vardakou, C. Pistos, and C. Spiliopoulou Spice drugs as a new trend: mode of action, identification and legislation Toxicol. Lett. 197 3 2010 157 162
35. D. Vearrier, and K.C. Osterhoudt A teenager with agitation: higher than she should have climbed Pediatr. Emerg. Care 26 6 2010 462 465
36. V. Vindenes, D. Jordbru, A.B. Knapskog, E. Kvan, G. Mathisrud, L. Slordal, and J. Morland Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway Forensic Sci. Int. 219 1-3 2012 1 11
37. V. Vindenes, D.H. Strand, L. Kristoffersen, F. Boix, and J. Morland Has the intake of thc by cannabis users changed over the last decade? Evidence of increased exposure by analysis of blood thc concentrations in impaired drivers Forensic Sci. Int. 226 1-3 2013 197 201
38. P.F. Waller, F.C. Blow, R.F. Maio, K. Singer, E.M. Hill, and N. Schaefer Crash characteristics and injuries of victims impaired by alcohol versus illicit drugs Accid. Anal. Prev. 29 6 1997 817 827 (Pubitemid 127399061)
39. D.L. Wells, and C.A. Ott The "new" marijuana Ann. Pharmacother. 45 3 2011 414 417
40. A.R. Winstock, L.R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, and F. Schifano Mephedrone, new kid for the chop? Addiction (Abingdon, England) 106 1 2011 154 161
41. A. Wintermeyer, I. Moller, M. Thevis, M. Jubner, J. Beike, M.A. Rothschild, and K. Bender In vitro phase i metabolism of the synthetic cannabimimetic JWH-018 Anal. Bioanal. Chem. 398 5 2010 2141 2153
42. J.K. Yeakel, and B.K. Logan Blood synthetic cannabinoid concentrations in cases of suspected impaired driving J. Anal. Toxicol. 2013
43. D. Zuba, B. Byrska, and M. Maciow Comparison of "herbal highs" composition Anal. Bioanal. Chem. 400 1 2011 119 126